Home | Welcome to Contract Pharma   
Last Updated Tuesday, May 21 2013
Print RSS Feed

Breaking News

Related Searches: Industry News

June 10, 2009
Velesco Pharmaceutical Services opened a manufacturing facility and office in Kalamazoo, MI and has moved its Ann Arbor, MI labs to the Michigan Life Science and Innovation Center (MLSIC) in Plymouth, MI.  Read More »

June 10, 2009
Raj Rai has been appointed interim chief executive officer of Akorn, Inc., while the board of directors looks for a permanent replacement.  Read More »

June 10, 2009
Millipore Corp. has opened its expanded single-use biomanufacturing facility in Danvers, MA.   Read More »

June 9, 2009
CSL Ltd. and Talecris Biotherapeutics, Inc. have terminated the merger agreement announced on August 12, 2008, under which CSL agreed to acquire Talecris for $3.1 billion in cash.  Read More »

June 9, 2009
ICON has signed a strategic partnership with Lilly to manage the company's clinical trial site setup and monitoring in Europe for managed studies.  Read More »

June 9, 2009
GlaxoSmithKline and Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. have entered into a definitive agreement to form a joint venture focused on developing and manufacturing flu vaccines for the Chinese market.  Read More »

June 8, 2009
Patheon's Swindon, UK facility has extended its aseptic vial-filling capabilities to include the commercial supply of small-scale specialty products.   Read More »

June 8, 2009
GlaxoSmithKline, Novartis, Roche, and Eli Lilly have joined forces to invest venture capital into Aileron Therapeutics, a biotech company based in Cambridge, MA that is using novel chemical structures to make a new class of medicines.  Read More »

June 8, 2009
MDS Pharma Services is renovating and expanding its discovery pharmacology operation in Taiwan.   Read More »

June 5, 2009
Ortho Biotech Oncology R&D, a unit of Centocor R&D, Inc., has entered into a five-year Cooperative R&D Agreement (CRADA) with the National Cancer Institute (NCI) to research and develop new cell therapy technologies as potential cancer treatments.  Read More »

June 5, 2009
Bart Peterson has been appointed senior vice president of corporate affairs and communications, Eli Lilly and Co.   Read More »

June 5, 2009
Merck's preliminary results for the Phase III study of rolofylline (MK-7418), an investigational medicine for the treatment of acute heart failure, shows that rolofylline did not meet the primary or secondary efficacy endpoints.  Read More »

June 4, 2009
Abbott and AstraZeneca have entered into an agreement under which the two companies will co-promote Abbott's cholesterol drug Trilipix (fenofibric acid) in the U.S. Financial terms were not disclosed.  Read More »

June 4, 2009
Dr. Betsy Garofalo has been named as the global therapy area leader for CNS, Astellas Pharma Global Development.  Read More »

June 4, 2009
OctoPlus N.V. has signed a new drug delivery technology evaluation contract for two compounds with a European biotech company.   Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On